GenTrust’s ProShares UltraShort Health Care RXD Stock Holding History

GenTrust’s Portfolio RXD Stock Details RXD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5,094	Closed	-$141K	–	142
2022 Q2	$141K	Buy	+5,094	New	+$138K	0.01%	140

Other funds holding RXD

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

GenTrust's RXD Position: Q3 2022 in Review

GenTrust sold out of ProShares UltraShort Health Care (RXD) in Q3 2022, closing a stake of 5,094 shares — an estimated $141K sold.

GenTrust first reported a position in RXD in Q2 2022 and held it in 1 quarter. The position peaked at $141K in Q2 2022. 3 funds tracked by Wall St. Rank hold RXD as of Q3 2022.

GenTrust reported no remaining ProShares UltraShort Health Care position as of Q3 2022 after selling out during the quarter.
GenTrust sold 5,094 ProShares UltraShort Health Care shares in Q3 2022, an estimated $141K.
GenTrust first reported a position in ProShares UltraShort Health Care in Q2 2022 and held it in 1 quarter.
GenTrust's ProShares UltraShort Health Care position peaked at $141K in Q2 2022.
3 funds tracked by Wall St. Rank held ProShares UltraShort Health Care as of Q3 2022.

Based on GenTrust's 13F filing for Q3 2022, filed 21 Oct 2022.